Somnomed
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 11 Aug 2026
- Reported shorts
- 669
- Shares on issue
- 219.768M
Somnomed (SOM) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26), figures in AUD, the reporting currency
- Revenue
- $114.5Mvs n/a
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- −$2.6Mvs n/a
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- −$0.012vs n/a
- Yahoo Finance, as at 14 Oct 2026
- Rev YoY
- n/aFY
- EPS YoY
- n/aTTM
Summary of Full Year Statutory Accounts, 28 Aug 2026
SomnoMed reported FY26 revenue of $114.5 million, up 2.7% from the prior year, with a net loss after tax of $2.65 million, improving from a $3.46 million loss in FY25. No dividend was declared for the year. The company targets high single-digit revenue growth in FY27 while maintaining EBITDA margins consistent with FY26.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 15 Oct 2026
- Gross margin
- 61.1%
- Operating margin
- 0.9%
- Net margin
- −2.3%
- FCF margin
- 2.2%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net cash (excl. leases)
- $16.8M
- Net debt / EBITDA
- −3.3×
- Current ratio
- 1.7×
- Interest cover
- 16.3×
- Cash dividends paid / net profit
- n/a
- Market cap
- $54.5M
- P/E
- n/a
- P/B
- 1.1×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Revenue | $114.5M | $91.7M | $83.6M | $72.6M |
| Gross profit | $70.0M | $55.1M | $51.9M | $44.3M |
| Operating income | $976.0K | −$8.3M | −$4.1M | −$4.1M |
| EBITDA | $5.1M | −$2.6M | $376.1K | $524.5K |
| EBIT | −$398.0K | −$8.4M | −$4.7M | −$3.4M |
| Interest expense | $60.0K | $2.9M | $2.3M | $84.0K |
| Pretax income | −$458.0K | −$11.3M | −$7.0M | −$3.5M |
| Tax | $2.2M | $971.1K | $821.6K | $930.6K |
| NPAT | −$2.6M | −$12.2M | −$8.0M | −$4.4M |
| Net interest income | −$377.0K | −$3.1M | −$2.6M | −$379.9K |
| EPS basic | −$0.012 | −$0.10 | −$0.075 | −$0.042 |
| EPS diluted | −$0.012 | −$0.10 | −$0.075 | −$0.042 |
| Shares | 217.9M | 211.9M | 106.2M | 106.2M |
Financial reports
The company's own filings, newest first
- Full year results announcement FY26Full Year Results28 Aug 2026via asx_announcements
- Full Year Statutory AccountsFull Year Results28 Aug 2026via asx_announcements
- Half year results announcement FY26Half Year Results27 Feb 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results27 Feb 2026via asx_announcements
- Quarterly reportingQuarterly Report22 Oct 2025via asx_announcements
- Annual Report & full year resultsAnnual Report28 Aug 2025via asx_announcements
- Full year results announcement FY25Full Year Results28 Aug 2025via asx_announcements
- FY25 Financial Results release date and webinar detailsFinancial Report7 Aug 2025via asx_announcements
- Quarterly Activities ReportQuarterly Report29 Jul 2025via asx_announcements
- Quarterly Activities ReportQuarterly Report30 Apr 2025via asx_announcements
Showing 10 of 25 reports